疫苗開發的智財與商業議題

主講人：
Yi-Chun Maria Chen, PhD
Specialized in biotechnology and pharmaceutical business development with 6 years of deal making and over 2 years of direct sale experience. A cell immunologist with 7-year post-graduate experience in T and B cell activation signaling pathways, and specialized in immunoassay and microscopy.

學歷：
PhD: Stony Brook University, Stony Brook, NY, United States
BS: National Tsing Hua University (NTHU), Hsinchu, Taiwan

經歷：
Dec, 2020 to present               Vice President of Scientific Operation, BRIM Biotechnology, Inc.
Nov, 2015 to Nov, 2020         Director of Business Development, Immunwork, Inc.
Jun, 2015 to May, 2016         Technical Inside Sales/ Consultant, Advanced Cell Diagnostics Inc

學術研究：
Mar, 2012 to May, 2015        Genentech, Inc, ITGR-Diagnostic Discovery, Immunology Discovery Department
Aug, 2008 to Oct, 2011           University of California at San Francisco (UCSF), Department of Pathology
Jun, 2002 to Jul, 2008            Cold Spring Harbor Laboratory

著作：
[01] Chen, Y.-C. M., Kappel, C., Eils, R., and Spector, D. L. “Live Cell Dynamics of PML Nuclear Bodies upon Entry into and Exit from Mitosis.” Molecular Biology of the Cell (2008) 19, 3147-3162
[02] Dimitrova, N., Chen, Y.-C. M., Spector, D.L., de Lange, T. “53BP1 Promotes Non-Homologous End Joining of Telomeres by Increasing Chromatin Mobility.” Nature (2008) 456, 524-528
[03] Zhang, Y. F., Chen, Y.-C. M., Krummel, M. F., Rosen, S. D. “Functions of Lysophosphatidic Acid in T Cell Transmigration.” Journal of Immunology (2012) 189, 3914-3924
[04] Gilden, J. K., Chen, Y.-C. M., Peck, S., Krummel, M. F. “The Septin Cytoskeleton Facilitates Membrane Retraction during Motility and Blebbing.” Journal of Cell Biology (2012) 196, 103-114
[05] Chen, J. H., Lin, C. Y., Chen, Y.-C. M., Tian, W. T., Chu, H. M., Chang, T. W. “Bispecific Antibody Binding To RANKL and Osteonectin with Enhanced Localization to the Bone.” Molecular Pharmaceutics (2017) 14, 4113–4120

演講主題：
疫苗開發的智財與商業議題